SHPH - Shuttle Pharmaceuticals Holdings, Inc.
0.695
0 0%
Share volume: 300
Last Updated: Wed 05 Feb 2025 08:30:24 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.19%
PREVIOUS CLOSE
CHG
CHG%
$0.70
0.00
0.00%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-09-04 | 2024-09-04 | 2024-11-13 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 910.713 K | 955.757 K | 1.730 M | |
| Selling general and admin | 324.609 K | 310.038 K | 328.995 K | |
| Research and development | 586.104 K | 645.719 K | 1.401 M | |
| Total expenses | 1.385 M | 1.483 M | 3.052 M | |
| 7.06% | 105.82% | |||
| Operating income | -1.385 M | -1.483 M | -3.052 M | |
| Ebit | -1.259 M | -1.654 M | -3.570 M | |
| Pretax income | -1.735 M | -2.031 M | -3.784 M | |
| 17.07% | 86.30% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.731 M | -2.031 M | -3.784 M | |
| -17.34% | -86.30% |